AOD-9604 prices

FROM PEPTIDES CALCULATOR

About AOD9604

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

AOD-9604 is a 16-amino-acid peptide taken from the tail end of human growth hormone, residues 177 to 191, with a tyrosine added at the front to stabilize it and a disulfide bond closing a loop between its two cysteines. It came out of Monash University in Melbourne and was developed by Metabolic Pharmaceuticals as an oral obesity tablet across six trials in roughly 900 people between 2001 and 2006, none of which showed a convincing weight-loss effect. The pivotal 24-week study missed its primary endpoint and the company ended obesity development in February 2007; the molecule was later renamed LAT8881 by Lateral Pharma and tested for nerve pain, where it again failed to separate from placebo. It is approved nowhere, is prohibited by WADA, and an FDA advisory committee voted in December 2024 against adding it to the list of substances allowed in pharmacy compounding.

Formula

C78 H123 N23 O23 S2

Molar mass

1,815.1 g/mol

CAS number

221231-10-3

Amino acids

16

Research evidence described in the source

Limitations noted in the source

• A tolerability signal is not evidence of efficacy.
• The pivotal negative trial is central to interpreting marketing claims.
• A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
• Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.